Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

BRUSSELS, Belgium, September 30 /PRNewswire/ --

- Spirent TestCenter(TM) 3000 Series Offers High Performance End-to-End Layer 2-7 Triple-Play Testing at Line Rate on Single Gigabit Port

ESPOO, Finland, September 30 /PRNewswire/ -- Fortum will gain approximately 1.5 million tonnes of emission reduction units (ERU) from Joint Implementation projects conducted at the Russian Territorial Generating Company No. 10 (TGC-10). The projects TGC-10 will implement include construction of new power generation facilities in the Tyumen and Chelyabinsk areas, and they will be conducted during the Kyoto Period (2008-2012) of the European Emissions Trading Scheme.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080930/323003 )

DALLAS, September 30 /PRNewswire/ --

- Entrust demonstrates perfect PKI certificate exchange for EAC interoperability test across multiple countries and vendors

At a key interoperability test for second-generation ePassports in Prague earlier this month, Entrust, Inc. (Nasdaq: ENTU) demonstrated a successful public key infrastructure (PKI) certificate exchange using United Kingdom and Slovenia systems in a multi-country test environment. Showcasing a "point- and-click" PKI system, Entrust confirmed that the security infrastructure for second-generation ePassports, based on Extended Access Control (EAC), is truly ready for global deployment.

READING, England, September 30 /PRNewswire/ -- DediPower, one of the UK's fastest growing managed hosting providers, this month celebrates its 10th anniversary. From small beginnings, today DediPower has '000's of customers ranging in size from rapidly growing "internet" innovators to large, well-established organisations and multinationals.

With origins in web development, founders Craig Martin, Spencer Tarring and Russell Champion, identified the growing need for reliable and effective web hosting solutions for their clients in the late 90's. This exciting market opportunity changed the direction of the company that today is focused on delivering dedicated hosting solutions in its two UK enterprise class data centres.

LONDON, September 30 /PRNewswire/ -- mvision, a UK Managed Network Service provider of video conferencing and telepresence solutions, was awarded TANDBERG's 2008 EMEA Managed Video Services Provider of the Year award. The award ceremony held during TANDBERG's Partner Summit in Barcelona recognised mvision for the way they have successfully developed, packaged and marketed their range of Managed Services.

OR AKIVA, Israel, September 30 /PRNewswire/ -- ITGI Medical, Ltd. (TASE: ITGI) a company engaged with research, development, manufacturing and marketing of heterologous tissue covered stents, announced that its second heterologous tissue covered stent - AneuGraft(R) received CE Mark approval.

AneuGraft(R) is a stent 100% covered with a heterologous tissue, designed to set a barrier between the coronary blood vessel wall and its lumen. It is intended for situations in tortuous vessels.

"AneuGraft(R) Pericardium Covered Stent is especially suitable for patients with tortuous vessels where other covered stents may not be adequate for use due to limitations resulting from tortuous anatomy," says Efri Argaman ITGI Medical CEO.